SPYRE THERAPEUTICS, INC. Investment Income, Net
SPYRE THERAPEUTICS, INC. (SYRE) reported Investment Income, Net of $10.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-04
- SPYRE THERAPEUTICS, INC. investment income, net for the quarter ending 2026-06-30 was $10.05M, a 71.14% increase year-over-year.
- SPYRE THERAPEUTICS, INC. investment income, net for the quarter ending 2026-03-31 was $7.00M, a 7.73% increase year-over-year.
- SPYRE THERAPEUTICS, INC. investment income, net for the quarter ending 2025-12-31 was $7.14M, a 23.60% increase year-over-year.
- SPYRE THERAPEUTICS, INC. investment income, net for the quarter ending 2025-09-30 was $5.38M, a 3.76% increase year-over-year.
- SPYRE THERAPEUTICS, INC. investment income, net for fiscal 2025 was $24.89M, a 16.77% increase from fiscal 2024.
- SPYRE THERAPEUTICS, INC. investment income, net for fiscal 2024 was $21.31M, a 246.71% increase from fiscal 2023.
- SPYRE THERAPEUTICS, INC. investment income, net for fiscal 2023 was $6.15M, a 634.41% increase from fiscal 2022.
- SPYRE THERAPEUTICS, INC. investment income, net for fiscal 2022 was $837.00K, a 654.05% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.05M 10-Q · filed 2026-08-04 | $17.05M 10-Q · filed 2026-08-04 | $24.19M derived: sum of 3 quarters · filed 2026-08-04 | $29.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $7.00M 10-Q · filed 2026-05-05 | $14.13M derived: sum of 2 quarters · filed 2026-05-05 | $19.51M derived: sum of 3 quarters · filed 2026-05-05 | $25.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $12.52M derived: sum of 2 quarters · filed 2026-02-19 | $18.39M derived: sum of 3 quarters · filed 2026-08-04 | $24.89M 10-K · filed 2026-02-19 |
| 2025-09-30 | $5.38M 10-Q · filed 2025-11-04 | $11.25M derived: sum of 2 quarters · filed 2026-08-04 | $17.75M 10-Q · filed 2025-11-04 | $23.52M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $5.87M 10-Q · filed 2026-08-04 | $12.37M 10-Q · filed 2026-08-04 | $18.14M derived: sum of 3 quarters · filed 2026-08-04 | $23.33M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $6.49M 10-Q · filed 2026-05-05 | $12.27M derived: sum of 2 quarters · filed 2026-05-05 | $17.45M derived: sum of 3 quarters · filed 2026-05-05 | $23.37M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.96M derived: sum of 2 quarters · filed 2026-02-19 | $16.88M derived: sum of 3 quarters · filed 2026-02-19 | $21.31M 10-K · filed 2026-02-19 |
| 2024-09-30 | $5.18M 10-Q · filed 2025-11-04 | $11.10M derived: sum of 2 quarters · filed 2025-11-04 | $15.54M 10-Q · filed 2025-11-04 | $19.66M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $5.92M 10-Q · filed 2025-08-05 | $10.35M 10-Q · filed 2025-08-05 | $14.48M derived: sum of 3 quarters · filed 2026-02-19 | $15.73M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $4.43M 10-Q · filed 2025-05-08 | $8.56M derived: sum of 2 quarters · filed 2026-02-19 | $9.81M derived: sum of 3 quarters · filed 2026-02-19 | $10.16M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $4.13M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19 | $5.38M derived: sum of 2 quarters · filed 2026-02-19 | $5.73M derived: sum of 3 quarters · filed 2026-02-19 | $6.15M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.25M 10-Q/A · filed 2024-11-18 | $1.60M derived: sum of 2 quarters · filed 2024-11-18 | $2.02M 10-Q/A · filed 2024-11-18 | $2.43M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $350.00K 10-Q/A · filed 2024-11-18 | $770.00K 10-Q/A · filed 2024-11-18 | $1.18M derived: sum of 3 quarters · filed 2025-02-27 | $1.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $420.00K 10-Q/A · filed 2024-11-18 | $830.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.12M derived: sum of 3 quarters · filed 2025-02-27 | $1.22M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $698.00K derived: sum of 2 quarters · filed 2025-02-27 | $802.00K derived: sum of 3 quarters · filed 2025-02-27 | $837.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $288.00K 10-Q · filed 2023-11-09 | $392.00K derived: sum of 2 quarters · filed 2023-11-09 | $427.00K 10-Q · filed 2023-11-09 | $461.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | $104.00K 10-Q · filed 2023-08-11 | $139.00K 10-Q · filed 2023-08-11 | $173.00K derived: sum of 3 quarters · filed 2024-11-18 | $209.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | $35.00K 10-Q · filed 2023-05-11 | $69.00K derived: sum of 2 quarters · filed 2024-11-18 | $105.00K derived: sum of 3 quarters · filed 2024-11-18 | $124.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $34.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $70.00K derived: sum of 2 quarters · filed 2024-11-18 | $89.00K derived: sum of 3 quarters · filed 2024-11-18 | $111.00K 10-K/A · filed 2024-11-18 |
| 2021-09-30 | $36.00K 10-Q · filed 2022-11-03 | $55.00K derived: sum of 2 quarters · filed 2022-11-03 | $77.00K 10-Q · filed 2022-11-03 | $121.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $19.00K 10-Q · filed 2022-08-04 | $41.00K 10-Q · filed 2022-08-04 | $85.00K derived: sum of 3 quarters · filed 2023-03-02 | $173.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-05 | $66.00K derived: sum of 2 quarters · filed 2023-03-02 | $154.00K derived: sum of 3 quarters · filed 2023-03-02 | $315.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $132.00K derived: sum of 2 quarters · filed 2023-03-02 | $293.00K derived: sum of 3 quarters · filed 2023-03-02 | $593.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $88.00K 10-Q · filed 2021-11-04 | $249.00K derived: sum of 2 quarters · filed 2021-11-04 | $549.00K 10-Q · filed 2021-11-04 | $981.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $161.00K 10-Q · filed 2021-08-05 | $461.00K 10-Q · filed 2021-08-05 | $893.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.48M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $300.00K 10-Q · filed 2021-05-10 | $732.00K derived: sum of 2 quarters · filed 2022-03-08 | $1.32M derived: sum of 3 quarters · filed 2022-03-08 | $1.94M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.02M derived: sum of 2 quarters · filed 2022-03-08 | $1.64M derived: sum of 3 quarters · filed 2022-03-08 | $2.14M 10-K · filed 2022-03-08 |
| 2019-09-30 | $585.00K 10-Q · filed 2020-11-05 | $1.20M derived: sum of 2 quarters · filed 2020-11-05 | $1.71M 10-Q · filed 2020-11-05 | $2.14M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | $619.00K 10-Q · filed 2020-08-10 | $1.13M 10-Q · filed 2020-08-10 | $1.55M derived: sum of 3 quarters · filed 2021-03-18 | $1.89M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $507.00K 10-Q · filed 2020-05-07 | $934.00K derived: sum of 2 quarters · filed 2021-03-18 | $1.27M derived: sum of 3 quarters · filed 2021-03-18 | $1.54M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $766.00K derived: sum of 2 quarters · filed 2021-03-18 | $1.03M derived: sum of 3 quarters · filed 2021-03-18 | $1.17M 10-K · filed 2021-03-18 |
| 2018-09-30 | $339.00K 10-Q · filed 2019-11-06 | $602.00K derived: sum of 2 quarters · filed 2019-11-06 | $745.00K 10-Q · filed 2019-11-06 | $895.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $263.00K 10-Q · filed 2019-08-06 | $406.00K 10-Q · filed 2019-08-06 | $556.00K derived: sum of 3 quarters · filed 2020-02-24 | $692.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $143.00K 10-Q · filed 2019-05-07 | $293.00K derived: sum of 2 quarters · filed 2020-02-24 | $429.00K derived: sum of 3 quarters · filed 2020-02-24 | $529.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $286.00K derived: sum of 2 quarters · filed 2020-02-24 | $386.00K derived: sum of 3 quarters · filed 2020-02-24 | $482.00K 10-K · filed 2020-02-24 |
| 2017-09-30 | $136.00K 10-Q · filed 2018-11-08 | $236.00K derived: sum of 2 quarters · filed 2018-11-08 | $332.00K 10-Q · filed 2018-11-08 | $403.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $100.00K 10-Q · filed 2018-08-09 | $195.00K 10-Q · filed 2018-08-09 | $267.00K derived: sum of 3 quarters · filed 2019-03-07 | $339.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $95.00K 10-Q · filed 2018-05-08 | $167.00K derived: sum of 2 quarters · filed 2019-03-07 | $239.00K derived: sum of 3 quarters · filed 2019-03-07 | $313.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $144.00K derived: sum of 2 quarters · filed 2019-03-07 | $218.00K derived: sum of 3 quarters · filed 2019-03-07 | $244.00K 10-K · filed 2019-03-07 |
| 2016-09-30 | $72.00K 10-Q · filed 2017-11-07 | $146.00K derived: sum of 2 quarters · filed 2017-11-07 | $172.00K 10-Q · filed 2017-11-07 | $183.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | $74.00K 10-Q · filed 2017-08-09 | $100.00K 10-Q · filed 2017-08-09 | $111.00K derived: sum of 3 quarters · filed 2018-03-13 | $116.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | $26.00K 10-Q · filed 2017-05-09 | $37.00K derived: sum of 2 quarters · filed 2018-03-13 | $42.00K derived: sum of 3 quarters · filed 2018-03-13 | $47.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $16.00K derived: sum of 2 quarters · filed 2018-03-13 | $21.00K derived: sum of 3 quarters · filed 2018-03-13 | $22.00K 10-K · filed 2018-03-13 |
| 2015-09-30 | $5.00K 10-Q · filed 2016-11-09 | $10.00K derived: sum of 2 quarters · filed 2016-11-09 | $11.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $5.00K 10-Q · filed 2016-08-09 | $6.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-19 | |||
| 2014-12-31 | $1.00K 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |